SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-097043
Filing Date
2023-12-19
Accepted
2023-12-19 18:00:01
Documents
1
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 16831
  Complete submission text file 0001213900-23-097043.txt   19601
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Issuer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0818
Vivo Capital Fund VIII, L.P. (Reporting) CIK: 0001618788 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 231498755

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Reporting) CIK: 0001618789 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 231498756

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0818
Vivo Capital Surplus Fund VIII, L.P. (Reporting) CIK: 0001628048 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 231498754